EU reaches deal to secure BioNTech/Pfizer vaccine – Spokesperson

Tue, Nov 10, 2020
By editor
2 MIN READ

Coronavirus Pandemic

The European Commission has wrapped up negotiations with BioNTech and Pfizer to secure doses of the company’s experimental Coronavirus vaccine for Europe, a spokesperson announced this on Tuesday.

EU commissioners were due to approve the agreement on Wednesday, Eric Mamer said at a Brussels press conference.

“Negotiations with the pharmaceutical industry have been concluded,’’ commission sources told dpa ahead of the official announcement.

The European Union’s executive branch has been negotiating for months with U.S pharmaceutical giant Pfizer and German firm BioNTech.

Following initial talks, the commission said back in September that it plans to secure up to 300 million vaccine doses from those developers.

Pfizer and BioNTech announced on Monday that their experimental vaccine is 90 percent effective in preventing Covid-19 and that they plan to apply for emergency authorisation with the United States’ Food and Drug Authority regulator next week.

Germany is to have access to 100 million doses of the vaccine once the drug has received regulatory approval, Health Minister Jens Spahn said earlier.

Spahn said he is expecting the European Commission to sign an agreement with the companies quickly.

“Rest assured, we will now bring this to a speedy conclusion,’’ the minister said. (dpa/NAN)

– Nov. 10, 2020 @ 18:29 GMT |

Tags:


Nepal reaches out to other countries for jabs amid raging second wave

NEPAL is using all platforms available to reach out to the international community to procure vaccines amid the devastating…

Read More
Nigeria to reserve 50% of AstraZeneca supply due to anticipated delay

FAISAL Shuaib, executive director of the National Primary Health Care Development Agency, NPHCDA, has said that only...

Read More
India records 352,000 new daily COVID-19 cases, 2,812 deaths

INDIA on Monday saw a new global record of 352,991 daily new COVID-19 infections as a second wave of the...

Read More